Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment.

Radohery GFR, Walz A, Gumpp C, Cherkaoui-Rbati MH, Gobeau N, Gower J, Davenport MP, Rottmann M, McCarthy JS, Möhrle JJ, Rebelo M, Demarta-Gatsi C, Khoury DS

Open source

DOI: 10.1128/aac.00114-22
Published: 2022 Jul 19
Container: Antimicrobial agents and chemotherapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1128/aac.00114-22,
  title = {Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment.},
  author = {Radohery GFR and Walz A and Gumpp C and Cherkaoui-Rbati MH and Gobeau N and Gower J and Davenport MP and Rottmann M and McCarthy JS and Möhrle JJ and Rebelo M and Demarta-Gatsi C and Khoury DS},
  year = {2022},
  journal = {Antimicrobial agents and chemotherapy},
  doi = {10.1128/aac.00114-22},
  url = {https://doi.org/10.1128/aac.00114-22}
}

RIS

TY  - JOUR
TI  - Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment.
AU  - Radohery GFR
AU  - Walz A
AU  - Gumpp C
AU  - Cherkaoui-Rbati MH
AU  - Gobeau N
AU  - Gower J
AU  - Davenport MP
AU  - Rottmann M
AU  - McCarthy JS
AU  - Möhrle JJ
AU  - Rebelo M
AU  - Demarta-Gatsi C
AU  - Khoury DS
PY  - 2022
JO  - Antimicrobial agents and chemotherapy
DO  - 10.1128/aac.00114-22
UR  - https://doi.org/10.1128/aac.00114-22
ER  -

APA

GFR, R., A, W., C, G., MH, C., N, G., J, G., MP, D., M, R., JS, M., JJ, M., M, R., C, D., & DS, K. (2022). Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.00114-22

Source records

pubmed · retrieved 2026-11-10T10:51:14.174Z